Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.08, $0.10 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.73 billion.

For earnings history and earnings-related data on Boston Scientific (BSX) click here.